Medical Weight Loss for Chico, California Residents

Chico, California residents get physician-supervised weight loss by telehealth from New Hope Weight Loss: a $119 doctor review, then compounded semaglutide from $166/month or tirzepatide from $233/month.

Physician-supervised GLP-1 programs from $166/month, serving Chico through telehealth from our Costa Mesa, California clinic. Doctor review $119. Over 5,400 patients treated.

Same physician, wherever you live in California: patients in Chico see the same Dr. Sharma and the same protocol as our Costa Mesa, California patients, just delivered by telehealth instead of in person. Results vary. Doctor review just $119 (medication separate).

Why Chico Residents Choose New Hope Weight Loss

Cost should not be a guessing game, and in Chico it is not. Our flat pricing means semaglutide from $166 a month, tirzepatide from $233 a month, and a $119 physician review, with the medication billed separately and nothing buried in fine print. People across California tell us the relief of simply knowing the number ahead of time is half the reason they finally got started.

If you are searching for medical weight loss in Chico, New Hope Weight Loss treats patients statewide by telehealth from our Costa Mesa, California clinic. Dr. Sharma reviews your history by secure video and, if appropriate, prescribes compounded semaglutide or tirzepatide shipped to you.

You do not need a clinic on your street in Chico to work with a real physician, because everything Dr. Sharma offers from Costa Mesa reaches patients across California by secure telehealth. We care for patients throughout downtown Chico, the university district, and the northern Sacramento Valley. Every prescription is reviewed and authorized by Dr. Anjmun Sharma, MD, before anything is sent to your address in California.

By handling visits through telehealth, we serve every neighborhood in Chico, from downtown Chico, the university district, and the northern Sacramento Valley, without asking anyone to travel. Patients anywhere in California, including the downtown Chico, the university district, and the northern Sacramento Valley neighborhoods, get the same pricing because care is delivered by telehealth from our Costa Mesa clinic. California is our home state and our physical clinic sits in Costa Mesa, but we care for patients across the rest of the state by secure telehealth.

GLP-1 Weight Loss Programs Available

Begin your reset: semaglutide, from $166/mo

The 90-Day Metabolic Reset gives Chico patients a structured three-month plan with semaglutide, the active ingredient shared with Wegovy and Ozempic. Choose $166 a month or $499 for the whole 90 days. In trials of the branded drug, the average was around 15 to 17 percent body-weight loss. Compounded semaglutide is not FDA-approved and not brand-identical, and results vary.

Go further: tirzepatide, from $233/mo

Tirzepatide hits both GLP-1 and GIP receptors for a dual effect. Qualifying doses in branded-drug trials reached up to 22.5 percent loss, which is not what most patients should expect. It carries the same active ingredient as Mounjaro and Zepbound.

Each plan begins with a $119 physician review. Medication is billed separately. HSA, FSA, Klarna, and Affirm accepted.

How Telehealth Works for Chico

Telehealth means your weight-loss care travels to you instead of the other way around. Patients across Chico and the rest of start with a detailed online quiz covering medical history and goals. Dr. Anjmun Sharma personally reviews each intake and connects by secure video, usually inside 48 hours, to decide together whether a compounded GLP-1 is right. When she writes a prescription, the medication is filled by a state-licensed 503(a) pharmacy and mailed to your Chico door in temperature-controlled cold-pack packaging. Ongoing follow-ups also happen by video, keeping your plan on track without a single in-person appointment.

Frequently Asked Questions, Chico

Can people from Chico get treated by New Hope Weight Loss?

Absolutely. We operate one physical clinic in Costa Mesa, California, and we provide telehealth care to Chico, California. Whether you are in downtown Chico, the university district, and the northern Sacramento Valley or elsewhere in the area, the path is the same. Dr. Anjmun Sharma meets you by video and confirms if a compounded GLP-1 program is right for you.

Do Chico patients ever have to come into the office?

Never. Care is delivered entirely through telehealth, which means Chico residents stay home for consults, follow-ups, and questions. Once Dr. Sharma approves you, your compounded semaglutide or tirzepatide is mailed to Chico inside cold-pack packaging that holds the right temperature in transit.

What is the cost breakdown for Chico?

You pay $119 for the physician review. Semaglutide begins at $166 a month, or $499 across 90 days, and tirzepatide begins at $233 a month. Medication is a separate charge. We accept HSA, FSA, Klarna, and Affirm payments, and there is no distance surcharge applied to anyone in Chico.

What areas of Chico do you serve?

We serve patients from across Chico by telehealth, including downtown Chico, the university district, and the northern Sacramento Valley.

How does telehealth treatment work for Chico patients?

You complete the online medical intake, Dr. Sharma reviews your history by secure video, typically within 48 hours, and if you are a candidate and telehealth-eligible, compounded medication ships to your Chico address. Follow-ups also happen by video.

Chico Residents, Get Started Today

Doctor review $119. Semaglutide from $166/mo. Tirzepatide from $233/mo. Medication separate.

Start My Journey →

New Hope Weight Loss | clinic at 1503 South Coast Drive, Suite 322, Costa Mesa, CA 92626 | (657) 837-3342 | Serving Chico, California by telehealth. Telehealth availability and eligibility are confirmed during the medical consultation.

Wegovy® and Ozempic® are registered trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are registered trademarks of Eli Lilly and Company. New Hope Weight Loss is not affiliated with or endorsed by these companies. Compounded semaglutide and tirzepatide are prepared by licensed U.S. pharmacies and are not FDA-approved, not brand-identical, and not reviewed by the FDA for safety, effectiveness, or quality.